Literature DB >> 25447315

Cycling with BRCA2 from DNA repair to mitosis.

Hyunsook Lee1.   

Abstract

Genetic integrity in proliferating cells is guaranteed by the harmony of DNA replication, appropriate DNA repair, and segregation of the duplicated genome. Breast cancer susceptibility gene BRCA2 is a unique tumor suppressor that is involved in all three processes. Hence, it is critical in genome maintenance. The functions of BRCA2 in DNA repair and homology-directed recombination (HDR) have been reviewed numerous times. Here, I will briefly go through the functions of BRCA2 in HDR and focus on the emerging roles of BRCA2 in telomere homeostasis and mitosis, then discuss how BRCA2 exerts distinct functions in a cell-cycle specific manner in the maintenance of genomic integrity.
Copyright © 2014 The Author. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRCA2; Cell cycle; HDR (homology-directed recombination); Replication fork; Spindle assembly checkpoint (SAC)

Mesh:

Substances:

Year:  2014        PMID: 25447315     DOI: 10.1016/j.yexcr.2014.10.008

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Dynamic interaction of BRCA2 with telomeric G-quadruplexes underlies telomere replication homeostasis.

Authors:  Junyeop Lee; Keewon Sung; So Young Joo; Jun-Hyeon Jeong; Seong Keun Kim; Hyunsook Lee
Journal:  Nat Commun       Date:  2022-06-13       Impact factor: 17.694

2.  Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer.

Authors:  Avital Lev; Safoora Deihimi; Elena Shagisultanova; Joanne Xiu; Amriti R Lulla; David T Dicker; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742

3.  CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival.

Authors:  Jordi Minguillón; María José Ramírez; Llorenç Rovirosa; Pilar Bustamante-Madrid; Cristina Camps-Fajol; Gorka Ruiz de Garibay; Hermela Shimelis; Helena Montanuy; Roser Pujol; Gonzalo Hernandez; Massimo Bogliolo; Pau Castillo; Penny Soucy; Griselda Martrat; Antonio Gómez; Daniel Cuadras; María J García; Javier Gayarre; Conxi Lázaro; Javier Benítez; Fergus J Couch; Miquel Angel Pujana; Jordi Surrallés
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

4.  Paradoxical delay of senescence upon depletion of BRCA2 in telomerase-deficient worms.

Authors:  Mi-Sun Kwon; Jaewon Min; Hee-Yeon Jeon; Kwangwoo Hwang; Chuna Kim; Junho Lee; Je-Gun Joung; Woong-Yang Park; Hyunsook Lee
Journal:  FEBS Open Bio       Date:  2016-09-07       Impact factor: 2.693

5.  Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.

Authors:  María Abáigar; Cristina Robledo; Rocío Benito; Fernando Ramos; María Díez-Campelo; Lourdes Hermosín; Javier Sánchez-Del-Real; Jose M Alonso; Rebeca Cuello; Marta Megido; Juan N Rodríguez; Guillermo Martín-Núñez; Carlos Aguilar; Manuel Vargas; Ana A Martín; Juan L García; Alexander Kohlmann; M Consuelo Del Cañizo; Jesús M Hernández-Rivas
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

Review 6.  Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets.

Authors:  Alexandros Karagiannakos; Maria Adamaki; Antonis Tsintarakis; Borek Vojtesek; Robin Fåhraeus; Vassilis Zoumpourlis; Konstantinos Karakostis
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

7.  Long-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features.

Authors:  Robert Gelfand; Dolores Vernet; Kevin Bruhn; Jaydutt Vadgama; Nestor F Gonzalez-Cadavid
Journal:  Int J Oncol       Date:  2016-03-29       Impact factor: 5.650

Review 8.  The Knowns Unknowns: Exploring the Homologous Recombination Repair Pathway in Toxoplasma gondii.

Authors:  Ignacio M Fenoy; Silvina S Bogado; Susana M Contreras; Vanesa Gottifredi; Sergio O Angel
Journal:  Front Microbiol       Date:  2016-05-03       Impact factor: 5.640

9.  Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancers.

Authors:  Yoo-Kyung Lee; Noh-Hyun Park; Hyunsook Lee
Journal:  Exp Mol Med       Date:  2015-11-20       Impact factor: 8.718

Review 10.  Understanding BRCA2 Function as a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage Responses.

Authors:  Paul R Andreassen; Joonbae Seo; Constanze Wiek; Helmut Hanenberg
Journal:  Genes (Basel)       Date:  2021-07-02       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.